Praxis Precision Medicines Stock Today

PRAX Stock  USD 71.87  0.86  1.18%   

Performance

11 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Less than 28

 
High
 
Low
Below Average
Praxis Precision is trading at 71.87 as of the 7th of November 2024; that is 1.18 percent decrease since the beginning of the trading day. The stock's open price was 72.73. Praxis Precision has about a 28 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Praxis Precision Medicines are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of October 2024 and ending today, the 7th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
16th of October 2020
Category
Healthcare
Classification
Health Care
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 17.76 M outstanding shares of which 1.72 M shares are at this time shorted by private and institutional investors with about 5.84 trading days to cover. More on Praxis Precision Medicines

Moving together with Praxis Stock

  0.81VRDN Viridian TherapeuticsPairCorr
  0.85BMY Bristol Myers Squibb Aggressive PushPairCorr

Moving against Praxis Stock

  0.83ERNA Eterna TherapeuticsPairCorr
  0.83EVGN EvogenePairCorr
  0.79VALN Valneva SE ADRPairCorr
  0.78DYAI Dyadic InternationalPairCorr
  0.76MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.62PTN Palatin TechnologiesPairCorr

Praxis Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO PresidentMarcio MBA
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.02220.025
Fairly Down
Slightly volatile
Gross Profit Margin0.660.74
Fairly Down
Slightly volatile
Total Current Liabilities21.4 M15.7 M
Significantly Up
Slightly volatile
Non Current Liabilities Total2.9 M2.5 M
Fairly Up
Slightly volatile
Total Assets158.9 M87.9 M
Way Up
Slightly volatile
Total Current Assets155.8 M84.9 M
Way Up
Slightly volatile
Debt Levels
Praxis Precision can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Praxis Precision's financial leverage. It provides some insight into what part of Praxis Precision's total assets is financed by creditors.
Liquidity
Praxis Precision Medicines currently holds 2.5 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Praxis Precision Med has a current ratio of 4.47, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Praxis Precision's use of debt, we should always consider it together with its cash and equity.

Capital Expenditures

47,500
Praxis Precision Medicines (PRAX) is traded on NASDAQ Exchange in USA. It is located in 99 High Street, Boston, MA, United States, 02110 and employs 82 people. Praxis Precision is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.29 B. Praxis Precision Med conducts business under Biotechnology sector and is part of Health Care industry. The entity has 17.76 M outstanding shares of which 1.72 M shares are at this time shorted by private and institutional investors with about 5.84 trading days to cover. Praxis Precision Medicines currently holds about 165.4 M in cash with (111.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7.
Check Praxis Precision Probability Of Bankruptcy
Ownership Allocation
The majority of Praxis Precision Medicines outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Praxis Precision Med to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Praxis Precision. Please pay attention to any change in the institutional holdings of Praxis Precision Med as this could imply that something significant has changed or is about to change at the company.
Check Praxis Ownership Details

Praxis Stock Institutional Holders

InstituionRecorded OnShares
Soleus Capital Management, L.p.2024-06-30
533 K
Partner Fund Management Lp2024-06-30
453.1 K
Vestal Point Capital Lp2024-06-30
440 K
Kingdon Capital Management Llc2024-06-30
415 K
Geode Capital Management, Llc2024-06-30
395.1 K
Deep Track Capital, Lp2024-06-30
389.5 K
Hhg Plc2024-06-30
381.7 K
Morgan Stanley - Brokerage Accounts2024-06-30
368.6 K
Velan Capital Investment Management Lp2024-06-30
350.7 K
Blackrock Inc2024-06-30
1.3 M
Ra Capital Management, Llc2024-06-30
1.2 M
View Praxis Precision Diagnostics

Praxis Precision Historical Income Statement

At this time, Praxis Precision's Interest Expense is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 447.3 K in 2024, despite the fact that Tax Provision is likely to grow to (4.3 K). View More Fundamentals

Praxis Stock Against Markets

Praxis Precision Corporate Management

Dr BCoFounder OfficerProfile
Timothy KellyCFO TreasurerProfile
Nicole SweenyChief OfficerProfile
Kelly McCueChief OfficerProfile
Alyssa WyantChief OfficerProfile
Megan SniecinskiChief OfficerProfile
Lauren MastrocolaVP OfficerProfile

Additional Tools for Praxis Stock Analysis

When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.